Factory-Direct Model for Functional and Prescription Pet Food Brands

📌 Background

In 2026, the Chinese pet food market is witnessing a shift toward domestic brands and premium fresh food, with functional and prescription diets emerging as high-margin segments. Brokerage reports indicate that the penetration rate of professional pet food in China is approximately 43% for cats and 25% for dogs, significantly lower than the 90%+ seen in the US and Japan. Premium food accounts for about 35% of the market, below the global average of 47%. While the leading enterprise holds a 6.2% market share, long-tail brands with less than 1% share collectively still account for approximately 74% of the market (based on brokerage report data).

👤 Target Customers

Pet-owning households, veterinary clinics, and online distributors

💰 Revenue Streams

1) Private label premium: Generating brand premium profits through the sale of functional and prescription foods; 2) OEM exports: Earning processing fees from overseas client orders; 3) E-commerce direct sales: Direct-to-consumer sales via online platforms; 4) Offline distribution: Distributing through veterinary clinics and dealer networks based on supply volume (opportunity item, scale figures currently unavailable).

🧮 Cost Structure

Costs of raw materials such as animal proteins and functional ingredients, depreciation of factory equipment and production lines, R&D and veterinary collaboration expenses, and e-commerce platform advertising and channel rebates.

🛡️ Moat

Cost advantages derived from large-scale self-owned production capacity; functional formulas supported by a canine and feline nutritional R&D center; stable global supply chain and cross-border e-commerce export qualifications.

🔑 Keys to Success

• Increase R&D investment to achieve standardization and efficacy validation for prescription foods
• Balance resource allocation between OEM business and private label development
• Refined advertising and customer acquisition across all channels, particularly online e-commerce

⚠️ Risks

• Intensifying industry price wars leading to revenue growth without profit growth
• Inventory backlog caused by demand fluctuations following capacity expansion
• Regulatory tightening regarding claims for functional foods lacking clinical validation

🏢 Cases

• 乖宝宠物
• 中宠股份
• 网易严选宠粮

📊 SWOT Analysis